Literature DB >> 19092125

First morning voids are more reliable than spot urine samples to assess microalbuminuria.

Elsbeth C Witte1, Hiddo J Lambers Heerspink, Dick de Zeeuw, Stephan J L Bakker, Paul E de Jong, Ronald Gansevoort.   

Abstract

Measurement of urinary albumin excretion (UAE) in a 24-h collection is the gold standard method to determine the presence of microalbuminuria. We sought to compare more practical alternatives--measurement of urinary albumin concentration (UAC) or albumin:creatinine ratio (ACR)--in a first morning void or in a spot urine sample with this gold standard. We asked 241 participants of a prospective cohort study to make three 24-h urine collections, a first morning void, and a spot urine sample. Regression analysis showed that the ACR in a first morning void best agreed with 24-h UAE. The prevalence of microalbuminuria determined by data from a first morning void (7.5%, whether by UAC or ACR) nearly equaled the prevalence of microalbuminuria determined by 24-h UAE (10.0%), whereas the prevalence was higher when determined by spot urine samples (25.4% for UAC and 22.4% for ACR; both P < 0.001 versus 24-h UAE). The intraindividual coefficients of variation of the ACR in a first morning void and 24-h UAE were similar (19%). Intraindividual coefficients of variations of all other measurements of albuminuria were significantly greater. In conclusion, measurement of albuminuria in a first morning void, preferably as the ACR, is more reliable than a spot urine sample to diagnose and monitor microalbuminuria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19092125      PMCID: PMC2637059          DOI: 10.1681/ASN.2008030292

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  21 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

3.  Practical aspects of measuring microalbuminuria in diabetic patients.

Authors:  G Jermendy; K Farkas; J Nádas; A Daróczy; E Péterfai
Journal:  Diabetes Nutr Metab       Date:  2001-08

4.  Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin-creatinine ratio.

Authors:  W Y Ng; K F Lui; A C Thai
Journal:  Ann Acad Med Singapore       Date:  2000-01       Impact factor: 2.473

5.  Laser immunonephelometry for routine quantification of urinary albumin excretion.

Authors:  M Marre; J P Claudel; P Ciret; N Luis; L Suarez; P Passa
Journal:  Clin Chem       Date:  1987-02       Impact factor: 8.327

6.  Selecting the optimum specimen for assessing slight albuminuria, and a strategy for clinical investigation: novel uses of data on biological variation.

Authors:  J E Howey; M C Browning; C G Fraser
Journal:  Clin Chem       Date:  1987-11       Impact factor: 8.327

7.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

8.  Dietary nutrient intakes and slight albuminuria in people at least 40 years old.

Authors:  P A Metcalf; J R Baker; R K Scragg; E Dryson; A J Scott; C J Wild
Journal:  Clin Chem       Date:  1993-10       Impact factor: 8.327

9.  Single-void urine samples can be used to estimate quantitative microalbuminuria.

Authors:  D M Nathan; C Rosenbaum; V D Protasowicki
Journal:  Diabetes Care       Date:  1987 Jul-Aug       Impact factor: 19.112

10.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

View more
  77 in total

1.  Relationship between timed and spot urine collections for measuring phosphate excretion.

Authors:  Sven-Jean Tan; Edward R Smith; Michael M X Cai; Stephen G Holt; Tim D Hewitson; Nigel D Toussaint
Journal:  Int Urol Nephrol       Date:  2015-11-14       Impact factor: 2.370

Review 2.  Established and emerging markers of kidney function.

Authors:  Michael A Ferguson; Sushrut S Waikar
Journal:  Clin Chem       Date:  2012-02-06       Impact factor: 8.327

Review 3.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

Review 4.  Integrating albuminuria and GFR in the assessment of diabetic nephropathy.

Authors:  George Jerums; Sianna Panagiotopoulos; Erosha Premaratne; Richard J MacIsaac
Journal:  Nat Rev Nephrol       Date:  2009-07       Impact factor: 28.314

5.  Determining the Optimal Protocol for Measuring an Albuminuria Class Transition in Clinical Trials in Diabetic Kidney Disease.

Authors:  Tobias F Kröpelin; Dick de Zeeuw; Giuseppe Remuzzi; Rudy Bilous; Hans-Henrik Parving; Hiddo J L Heerspink
Journal:  J Am Soc Nephrol       Date:  2016-04-07       Impact factor: 10.121

6.  Changes in albuminuria predict mortality and morbidity in patients with vascular disease.

Authors:  Roland E Schmieder; Johannes F E Mann; Helmut Schumacher; Peggy Gao; Giuseppe Mancia; Michael A Weber; Matthew McQueen; Teo Koon; Salim Yusuf
Journal:  J Am Soc Nephrol       Date:  2011-06-30       Impact factor: 10.121

7.  Biological Variability of Estimated GFR and Albuminuria in CKD.

Authors:  Sushrut S Waikar; Casey M Rebholz; Zihe Zheng; Shelley Hurwitz; Chi-Yuan Hsu; Harold I Feldman; Dawei Xie; Kathleen D Liu; Theodore E Mifflin; John H Eckfeldt; Paul L Kimmel; Ramachandran S Vasan; Joseph V Bonventre; Lesley A Inker; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2018-07-18       Impact factor: 8.860

8.  The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: the South London Diabetes cohort (SOUL-D).

Authors:  K Winkley; S M Thomas; S Sivaprasad; M Chamley; D Stahl; K Ismail; S A Amiel
Journal:  Diabetologia       Date:  2013-03-14       Impact factor: 10.122

9.  Glomerular and tubular damage markers in individuals with progressive albuminuria.

Authors:  Ferdau L Nauta; Lieneke Scheven; Esther Meijer; Wim van Oeveren; Paul E de Jong; Stephan J L Bakker; Ron T Gansevoort
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

10.  Microalbuminuria in HIV disease.

Authors:  Colleen Hadigan; Elizabeth Edwards; Alice Rosenberg; Julia B Purdy; Estee Fleischman; Lilian Howard; JoAnn M Mican; Karmini Sampath; Akinbowale Oyalowo; Antoinette Johnson; Alexandra Adler; Catherine Rehm; Margo Smith; Leon Lai; Jeffrey B Kopp
Journal:  Am J Nephrol       Date:  2013-04-20       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.